Association of Polycystic Ovarian Syndrome with Metabolic Disorders
DOI:
https://doi.org/10.51985/JBUMDC202221Keywords:
Central obesity, Hypertension, lipid profile, Metabolic Syndrome, Polycystic Ovarian SyndromeAbstract
Objective: To determine the association of Metabolic Disorders in women of reproductive age with polycystic ovarian
syndrome (PCOS)
Study Design and setting: Cross Sectional Study conducted in the Department of Gynecology and Obstetrics, Ward 9,
Jinnah Postgraduate Medical Center, Karachi.
Methodology: The study was conducted from November 2021 to February 2022. A total of 227 diagnosed patients of
PCOS were included in this study. Five components of Metabolic syndrome were assessed: Body Mass Index (BMI), blood
pressure, central obesity, fasting blood sugar and lipid profile. Informed consent was obtained from all participants. Patients’
history, physical examination and laboratory investigations in terms of symptoms and findings relating to MS were recorded
and assessed using SPSS version 21. Descriptive statistics were calculated and stratification was done. Chi-square test used
post stratification and p-value =0.05 were considered significant.
Results: Mean age was 27.05±4.51 years. Mean symptom duration was 11.26±3.02 months. Central obesity, hypertension,
hypertriglyceridemia, HDL-cholesterol <50 mg/dl and fasting glucose >100 mg/dl were found in 44.9%, 31.7%, 38.3%,
27.3%, and 38.8% patients, respectively. A total of 47 (20.7%) study subjects were identified with two or more above
components of MS. Significant association of MS with age (>27 years; p<0.000) and duration of disease (>12 months;
p<0.000) was observed.
Conclusion: A higher prevalence of MS was observed when participants aged more than 27 years and had symptoms for
more than a year. Higher BMI was also found nearing statistical significance.
References
Hallajzadeh J, Khoramdad M, Karamzad N, Almasi-Hashiani
A, Janati A, Ayubi E, et al. Metabolic syndrome and its
components among women with polycystic ovary syndrome:
a systematic review and meta-analysis. J Cardiovasc Thorac
Res. 2018;10 (2): 56-69 DOI: https://doi.org/10.15171/
JCVTR.2018.10.
Sidra S, Tariq MH, Farrukh MJ, Mohsin M. Evaluation of
clinical manifestations, health risks, and quality of life among
women with polycystic ovary syndrome. PLoS One. 2019;14
(10):e0223329. DOI:https://doi.org/ 10.1371/ journal.
pone.0223329.
Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian
syndrome (PCOS): Long-term metabolic consequences.
Metabolism. 2018; 86: 33-43. DOI:https://doi.org/ 10.1016/
j.metabol.2017.09.016.
Mu L, Zhao Y, Li R, Lai Y, Chang HM, Qiao J. Prevalence
of polycystic ovary syndrome in a metabolically healthy obese
population. Int J Gynaecol Obstet. 2019; 146 (2):164-169
DOI: https://doi.org/ 10.1002/ijgo.12824.
Anjum S, Askari S, Riaz M, Basit A. Clinical Presentation
and Frequency of Metabolic Syndrome in Women With
Polycystic Ovary Syndrome: An Experience From a Tertiary
Care Hospital in Pakistan. Cureus. 2020; 12(12):e11860. DOI:
https://doi.org/10.7759/cureus.11860.
Copp T, Hersch J, Muscat DM, McCaffery KJ, Doust J,
Dokras A, Mol BW, Jansen J. The benefits and harms of
receiving a polycystic ovary syndrome diagnosis: a qualitative
study of women's experiences. Hum Reprod Open. 2019;
(4):hoz026. DOI: https://doi.org/ 10.1093/ hropen/hoz026
Saif-Ali R, Kamaruddin NA, Al-Habori M, Al-Dubai SA,
Ngah W. Z. W. Relationship of metabolic syndrome defined
by IDF or revised NCEP ATP III with glycemic control among
Malaysians with Type 2 Diabetes. Diabetol. Metab. Syndr.
;12, 67 DOI: https://doi.org/10.1186/s13098-020-00575-
Najem F, Elmehdawi R, Swalem A. Clinical and biochemical
characteristics of polycystic ovary syndrome in BenghaziLibya: a retrospective study. Libyan J Med. 2008; 3:71-74.
4176/080122
Akram M, Roohi N. Endocrine correlates of polycystic ovary
syndrome in Pakistani women. J Coll Physicians Surg Pak.
; 25:22-26
Indhavivadhana S, Wongwananuruk T, Rattanachaiyanont M,
Techatraisak K, Leerasiri P, Tanmahasamut P, et al. Prevalence
of metabolic syndrome in reproductive-aged polycystic ovary
syndrome Thai women. J Med Assoc Thai. 2010; 93(6):653-
Deswal R, Narwal V, Dang A, Pundir CS. The Prevalence of
Polycystic Ovary Syndrome: A Brief Systematic Review. J
Hum Reprod Sci. 2020;13(4):261-271 DOI: https://doi.
org/10.4103/jhrs.JHRS_95_18.
Soares EM, Azevedo GD, Gadelha RG, Lemos TM, Maranhao
TM. Prevalence of the metabolic syndrome and its components
in Brazilian women with polycystic ovary syndrome. Fertil
Steril. 2008;89: 649-55
Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY,
et al. Cardiovascular risks and metabolic syndrome in Hong
Kong Chinese women with polycystic ovary syndrome. Hum
Reprod. 2008; 23:1431-8
Mandrelle K, Kamath MS, Bondu DJ, Chandy A, Aleyamma
TK, George K. Prevalence of metabolic syndrome in women
with polycystic ovary syndrome attending an infertility clinic
in a tertiary care hospital in south India. J Hum Reprod Sci.
; 5:26-31
Hahn S, Tan S, Sack S, Kimmig R, Quadbeck B, Mann K, et
al. Prevalence of the metabolic syndrome in German women
with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes.
;115:130-5
Anjum N, Zohra S, Arif A, Azhar A, Qureshi M: Prevalence
of metabolic syndrome in Pakistani women with polycystic
ovarian syndrome. Pak J Biochem Mol Biol. 2013; 46:97-
Shanmugham D, Natarajan S, Karthik A. Prevalence of thyroid
dysfunction in patients with polycystic ovarian syndrome: a
cross sectional study. Int J Reprod Contracept Obstet Gynecol.
; 7:3055-3059 DOI: https://doi.org/10.18203/2320-
ijrcog20182951
Basit A, Fawwad A, Qureshi H, Shera AS, NDSP Members.
Prevalence of diabetes, pre-diabetes and associated risk factors:
second National Diabetes Survey of Pakistan (NDSP), 2016-
BMJ Open. 2018; 8:e020961 DOI: https://doi.org/
1136/bmjopen-2017-020961
Chandrasekaran S, Sagili H. Metabolic syndrome in women
with polycystic ovary syndrome. Obstet Gynaecol. 2018;
:245-252 DOI:https://doi.org/ 10.1111/tog.12519
Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P,
Criscimanna A, Giordano C. Lower insulin sensitivity
differentiates hirsute from non-hirsute Sicilian women with
polycystic ovary syndrome. Eur J Endocrinol. 2006; 155:859-
Ramos R, Olden K. The prevalence of metabolic syndrome
among US women of childbearing age. Am J Publ Health.
; 98(6):1122-7
Maffazioli GDN, Lopes CP, Heinrich-Oliveira V, Lobo RA,
Hayashida SAY, Soares JM Jr, et al. Prevalence of metabolic
disturbances among women with polycystic ovary syndrome
in different regions of Brazil. Int J Gynaecol Obstet.
;151(3) :383-391 DOI:https://doi.org/ 10.1002/ijgo.13374
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Saba Khan, Sana Rehman, Geeta Chughani, Memoona Rehman, Erum Majid, Farheen Amir, Khadija Bano
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
